Indian stocks in focus: Cemindia's Rs 1,400 crore QIP and new deals
Roundup of October 21 corporate news: Cemindia Projects QIP, Orchid Pharma fundraising plan, Infosys and Transrail Lighting deals, plus orders from other companies.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to Moody's, 15 Indian companies were in focus for investors on October 21. Infosys is expanding its collaboration with Truist to support the bank's AI-first Global Capability Center in Hyderabad. Cemindia Projects, formerly ITD Cementation India, raised Rs 1,400 crore through a Qualified Institutions Placement, issuing shares at Rs 1,108, a 4.37% discount to the floor price. Orchid Pharma's board approved a plan to raise up to Rs 600 crore, while Transrail Lighting may acquire up to 49% of NOPL Pace Green Energy for up to Rs 20 crore.
why it matters
For markets, most of these items are routine corporate events of modest size. The most notable is the Cemindia placement, which shows institutional investors' appetite for a construction company's shares. The other announcements mainly affect individual stocks and are unlikely to move the broader index.
tags
instruments
sources
- Stocks to watch out for today, October 21: Infosys, Ceigall, Dhampur Bio, JSW Dulux, Venus Pipes, Transrail, Orchid Pharma among 15 stocks in focus — Moody's, 21 October 2026 at 05:03 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗